Information Provided By:
Fly News Breaks for April 25, 2017
Apr 25, 2017 | 12:52 EDT
Cantor Fitzgerald analyst Bryan Brokmeier raised his price target for Waters (WAT) to $190 citing the company's "strong" Q1 results. Consensus estimates continue under-appreciate the strength in Biopharma, the analyst tells investors in a post-earnings research note. He keeps an Overweight rating on Waters. Brokmeier views the company's earnings report as mixed for peers Bruker (BRKR) and PerkinElmer (PKI).
News For WAT;BRKR;PKI From the Last 2 Days
There are no results for your query WAT;BRKR;PKI
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.